🇺🇸 FDA
Patent

US 9574193

Methods and compositions for modulating apolipoprotein (a) expression

granted A61KA61K31/7115A61K31/712

Quick answer

US patent 9574193 (Methods and compositions for modulating apolipoprotein (a) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/7115, A61K31/712, A61K31/7125